Healthcare delivery organisations have been struck with obstacles from all sides, from personal protective equipment (PPE) and medical supply shortages to drug, resource, and personnel limits, and have increasingly relied on new techniques and industry alliances to make it through.

Industry stakeholders and patients in the healthcare supply chain have had a difficult 18 months, and many are still on the path to recovery. The bulk of healthcare supply chain hurdles were "hiding" in plain sight long before the pandemic, from a lack of timely, consumable data and inadequate visibility into what's causing supply chain failures to a lack of information exchange and interoperability.

Drug shortages and a "impaired" pharmaceutical supply chain, for example, have progressively afflicted the healthcare sector since the outbreak of the epidemic. During Covid-19, the Johns Hopkins Bloomberg School of Public Health released a paper that analyses some of the contributing causes to pharmaceutical supply chain difficulties both at home and overseas. These include issues such as a lack of understanding of local drug shortages and demand-driven drug shortages.

There are multiple dimensions to the challenges facing the supply chain. Fixing weaknesses is both an urgent task and a necessary step to improve resilience in the future.

What is needed and required to address today's healthcare supply chain concerns while laying a solid basis for the future? Technology, data, and the successful implementation of connectivity solutions that open up lines of communication and offer actionable data across healthcare stakeholder groups.

The industry's transition to value-based care is still underway, with new payment models emerging all the time. The following are five well-known strategic objectives for advancing healthcare system-wide transformations:

  • Encourage people to take responsibility for their own health.
  • Promote health equity.
  • Encourage new ideas.
  • Address the issue of affordability.
  • To reform the system, join forces with others.

For both health systems and suppliers, Covid-19 has been a testbed for innovation and a stress test. GPOs will likely continue to expand their core skills in the future, while using their market positions to have an effect at scale, according to the healthcare sector.